Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: J Urol. 2020 Jun 18;204(6):1173–1179. doi: 10.1097/JU.0000000000001199

Table 2.

Multivariable analysis showing 5 significant factors associated with survival in the derivation atezolizumab dataset

PI Coefficient HR 95% CI p-value
Log NLR 0.661 1.937 1.566–2.395 <0.001
ECOG-PS 0.583 1.792 1.362–2.358 <0.001
Log LDH 0.467 1.596 1.277–1.994 <0.001
Log Platelet count 0.796 2.217 1.544–3.182 <0.001
Liver metastasis 0.437 1.547 1.199–1.997 0.001

C-index of 5-factor model is 0.692 in the derivation dataset; The risk groups are based on PI categorization: PI <7.73681 (low risk), 7.73681≤ PI <8.91837 (moderate risk), PI ≥ 8.91837 (high risk). Legend: NLR=Neutrophils-lymphocyte ratio; ECOG-PS=Eastern Cooperative Oncology Group performance status; LDH=lactate dehydrogenase; HR=hazard ratio; CI=confidence interval